ATM and pachyonychia congenita: Based on the International Cancer of the Pancreas Screening Consortium (CAPS) consensus criteria, carriers with a family history of PC may be eligible for high-risk surveillance (such as Magnetic Resonance Imaging (MRI) or EUS if a pathogenic germline ATM variation is found.